Abstract
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disorder, defined clinically by degeneration of dopaminergic neurons and the development of neuronal Lewy bodies. Current treatments of PD are inadequate due to a limited understanding of molecular events of the disease, thus calling for intense research efforts towards identification of novel therapeutic targets. We carried out the present studies towards identifying novel genetic modulators of PD-associated effects employing a transgenic Caenorhabditis elegans model expressing human alpha-synuclein. Employing a systematic RNA interference (RNAi)-based screening approach, we studied a set of neuroprotective genes of C. elegans with an aim of identifying genes that exhibit protective function under alpha-synuclein expression conditions. Our results reveal a novel set of alpha-synuclein effector genes that modulate alpha-synuclein aggregation and associated effects. The identified genes include those from various gene families including histone demethylase, lactate dehydrogenase, small ribosomal subunit SA protein, cytoskeletal protein, collapsin response mediator protein, and choline kinase. The functional characterization of these genes reveals involvement of signaling mechanisms such as Daf-16 and acetylcholine signaling. Further elucidation of mechanistic pathways associated with these genes will yield additional insights into mediators of alpha-synuclein-induced cytotoxicity and cell death, thereby helping in the identification of potential therapeutic targets for PD.
Similar content being viewed by others
References
Petrucci S, Consoli F, Valente EM (2014) Parkinson disease genetics: a "continuum" from Mendelian to multifactorial inheritance. Curr Mol Med
Dai C, Liang D, Li H, Sasaki M, Dawson TM, Dawson VL (2010) Functional identification of neuroprotective molecules. PLoS One 5(11):e15008. doi:10.1371/journal.pone.0015008
Harris TW, Chen N, Cunningham F, Tello-Ruiz M, Antoshechkin I, Bastiani C, Bieri T, Blasiar D et al (2004) WormBase: a multi-species resource for nematode biology and genomics. Nucleic Acids Res 32(Database issue):D411–D417. doi:10.1093/nar/gkh066
Harrington AJ, Hamamichi S, Caldwell GA, Caldwell KA (2010) C. elegans as a model organism to investigate molecular pathways involved with Parkinson’s disease. Dev Dyn 239(5):1282–1295. doi:10.1002/dvdy.22231
Schmidt E, Seifert M, Baumeister R (2007) Caenorhabditis elegans as a model system for Parkinson’s disease. Neurodegener Dis 4(2–3):199–217. doi:10.1159/000101845
Nass R, Blakely RD (2003) The Caenorhabditis elegans dopaminergic system: opportunities for insights into dopamine transport and neurodegeneration. Annu Rev Pharmacol Toxicol 43:521–544. doi:10.1146/annurev.pharmtox.43.100901.135934100901.135934
Benedetto A, Au C, Aschner M (2009) Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson’s disease. Chem Rev 109(10):4862–4884. doi:10.1021/cr800536y
Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, Hill KJ, Caldwell KA, Caldwell GA et al (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41(3):308–315. doi:10.1038/ng.300
Hamamichi S, Rivas RN, Knight AL, Cao S, Caldwell KA, Caldwell GA (2008) Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson’s disease model. Proc Natl Acad Sci U S A 105(2):728–733. doi:10.1073/pnas.0711018105
Sakaguchi-Nakashima A, Meir JY, Jin Y, Matsumoto K, Hisamoto N (2007) LRK-1, a C. elegans PARK8-related kinase, regulates axonal-dendritic polarity of SV proteins. Curr Biol 17(7):592–598. doi:10.1016/j.cub.2007.01.074
Samann J, Hegermann J, von Gromoff E, Eimer S, Baumeister R, Schmidt E (2009) Caenorhabditis elegans LRK-1 and PINK-1 act antagonistically in stress response and neurite outgrowth. J Biol Chem 284(24):16482–16491. doi:10.1074/jbc.M808255200
Ved R, Saha S, Westlund B, Perier C, Burnam L, Sluder A, Hoener M, Rodrigues CM et al (2005) Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of alpha-synuclein, parkin, and DJ-1 in Caenorhabditis elegans. J Biol Chem 280(52):42655–42668. doi:10.1074/jbc.M505910200
Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77(1):71–94
Jadiya P, Nazir A (2014) A pre- and co-knockdown of RNAseT enzyme, Eri-1, enhances the efficiency of RNAi induced gene silencing in Caenorhabditis elegans. PLoS One 9(1):e87635. doi:10.1371/journal.pone.0087635
Jadiya P, Khan A, Sammi SR, Kaur S, Mir SS, Nazir A (2011) Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson’s disease. Biochem Biophys Res Commun 413(4):605–610. doi:10.1016/j.bbrc.2011.09.010
Jadiya P, Nazir A (2012) Environmental toxicants as extrinsic epigenetic factors for parkinsonism: studies employing transgenic C. elegans model. CNS Neurol Disord Drug Targets 11(8):976–983
Sashidhara KV, Modukuri RK, Jadiya P, Dodda RP, Kumar M, Sridhar B, Kumar V, Haque R et al (2014) Benzofuran-Chalcone hybrids as potential multifunctional agents against Alzheimer’s disease: synthesis and in vivo studies with transgenic Caenorhabditis elegans. ChemMedChem. doi:10.1002/cmdc.201402291
Sashidhara KV, Modukuri RK, Jadiya P, Rao KB, Sharma T, Haque R, Singh DK, Banerjee D et al (2014) Discovery of 3-arylcoumarin-tetracyclic tacrine hybrids as multifunctional agents against Parkinson’s disease. ACS Med Chem Lett 5(10):1099–1103. doi:10.1021/ml500222g
Kaur S, Sammi SR, Jadiya P, Nazir A (2012) RNAi of cat-2, a putative tyrosine hydroxylase, increases alpha synuclein aggregation and associated effects in transgenic C. elegans. CNS Neurol disord Drug Targets 11(4):387–394
Chiang WC, Tishkoff DX, Yang B, Wilson-Grady J, Yu X, Mazer T, Eckersdorff M, Gygi SP et al (2012) C. elegans SIRT6/7 homolog SIR-2.4 promotes DAF-16 relocalization and function during stress. PLoS Genet 8(9):e1002948. doi:10.1371/journal.pgen.100294821
Nottke AC, Beese-Sims SE, Pantalena LF, Reinke V, Shi Y, Colaiacovo MP (2011) SPR-5 is a histone H3K4 demethylase with a role in meiotic double-strand break repair. Proc Natl Acad Sci U S A 108(31):12805–12810. doi:10.1073/pnas.1102298108
Eimer S, Lakowski B, Donhauser R, Baumeister R (2002) Loss of spr-5 bypasses the requirement for the C. elegans presenilin sel-12 by derepressing hop-1. EMBO J 21(21):5787–5796
Katz DJ, Edwards TM, Reinke V, Kelly WG (2009) A C. elegans LSD1 demethylase contributes to germline immortality by reprogramming epigenetic memory. Cell 137(2):308–320. doi:10.1016/j.cell.2009.02.015
Rudolph T, Yonezawa M, Lein S, Heidrich K, Kubicek S, Schafer C, Phalke S, Walther M et al (2007) Heterochromatin formation in Drosophila is initiated through active removal of H3K4 methylation by the LSD1 homolog SU(VAR)3-3. Mol Cell 26(1):103–115. doi:10.1016/j.molcel.2007.02.025
Bany IA, Dong MQ, Koelle MR (2003) Genetic and cellular basis for acetylcholine inhibition of Caenorhabditis elegans egg-laying behavior. J Neurosci Off J Soc Neurosci 23(22):8060–8069
Kim J, Poole DS, Waggoner LE, Kempf A, Ramirez DS, Treschow PA, Schafer WR (2001) Genes affecting the activity of nicotinic receptors involved in Caenorhabditis elegans egg-laying behavior. Genetics 157(4):1599–1610
Greer EL, Brunet A (2009) Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell 8(2):113–127. doi:10.1111/j.1474-9726.2009.00459.x
Han S, Brunet A (2012) Histone methylation makes its mark on longevity. Trends Cell Biol 22(1):42–49. doi:10.1016/j.tcb.2011.11.001
Gee P, Kent C (2003) Multiple isoforms of choline kinase from Caenorhabditis elegans: cloning, expression, purification, and characterization. Biochim Biophys Acta 1648(1–2):33–42
Exton JH (1994) Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta 1212(1):26–42
Kent C, Carman GM (1999) Interactions among pathways for phosphatidylcholine metabolism, CTP synthesis and secretion through the Golgi apparatus. Trends Biochem Sci 24(4):146–150
Herman IM (1993) Actin isoforms. Curr Opin Cell Biol 5(1):48–55
Pollard TD, Cooper JA (1986) Actin and actin-binding proteins. A critical evaluation of mechanisms and functions. Annu Rev Biochem 55:987–1035. doi:10.1146/annurev.bi.55.070186.005011
Tilney LG, Connelly P, Smith S, Guild GM (1996) F-actin bundles in Drosophila bristles are assembled from modules composed of short filaments. J Cell Biol 135(5):1291–1308
Ben-Zvi A, Miller EA, Morimoto RI (2009) Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A 106(35):14914–14919. doi:10.1073/pnas.0902882106
Reis-Rodrigues P, Czerwieniec G, Peters TW, Evani US, Alavez S, Gaman EA, Vantipalli M, Mooney SD et al (2012) Proteomic analysis of age-dependent changes in protein solubility identifies genes that modulate lifespan. Aging Cell 11(1):120–127. doi:10.1111/j.1474-9726.2011.00765.x
Acknowledgments
C. elegans strains were obtained from the Caenorhabditis Genetics Center (CGC) University of Minnesota, MN, USA, which is funded by the NIH National Center for Research Resources (NCRR). The confocal microscopy facility of CSIR-CDRI is acknowledged for making the facility available to us; Dr. Kavita Singh is gratefully acknowledged for her help with imaging. A. N. acknowledges the financial support received from CSIR-NWP “UNDO” (BSC0103). P. J. is thankful to CSIR for the Senior Research Fellowship (Ref: 113558/2 K11/1). CSIR-CDRI communication number is 9114.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jadiya, P., Fatima, S., Baghel, T. et al. A Systematic RNAi Screen of Neuroprotective Genes Identifies Novel Modulators of Alpha-Synuclein-Associated Effects in Transgenic Caenorhabditis elegans . Mol Neurobiol 53, 6288–6300 (2016). https://doi.org/10.1007/s12035-015-9517-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-015-9517-3